Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Mol Metab ; 44: 101135, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33279727

RESUMEN

OBJECTIVE: Amylin was found to regulate glucose and lipid metabolism by acting on the arcuate nucleus of the hypothalamus (ARC). Maternal high-fat diet (HFD) induces sex-specific metabolic diseases mediated by the ARC in offspring. This study was performed to explore 1) the effect of maternal HFD-induced alterations in amylin on the differentiation of hypothalamic neurons and metabolic disorders in male offspring and 2) the specific molecular mechanism underlying the regulation of amylin and its receptor in response to maternal HFD. METHODS: Maternal HFD and gestational hyper-amylin mice models were established to explore the role of hypothalamic amylin and receptor activity-modifying protein 3 (Ramp3) in regulating offspring metabolism. RNA pull-down, mass spectrometry, RNA immunoprecipitation, and RNA decay assays were performed to investigate the mechanism underlying the influence of maternal HFD on Ramp3 deficiency in the fetal hypothalamus. RESULTS: Male offspring with maternal HFD grew heavier and developed metabolic disorders, whereas female offspring with maternal HFD showed a slight increase in body weight and did not develop metabolic disorders compared to those exposed to maternal normal chow diet (NCD). Male offspring exposed to a maternal HFD had hyperamylinemia from birth until adulthood, which was inconsistent with offspring exposed to maternal NCD. Hyperamylinemia in the maternal HFD-exposed male offspring might be attributed to amylin accumulation following Ramp3 deficiency in the fetal hypothalamus. After Ramp3 knockdown in hypothalamic neural stem cells (htNSCs), amylin was found to fail to promote the differentiation of anorexigenic alpha-melanocyte-stimulating hormone-proopiomelanocortin (α-MSH-POMC) neurons but not orexigenic agouti-related protein-neuropeptide Y (AgRP-Npy) neurons. An investigation of the mechanism involved showed that IGF2BP1 could specifically bind to Ramp3 in htNSCs and maintain its mRNA stability. Downregulation of IGF2BP1 in htNSCs in the HFD group could decrease Ramp3 expression and lead to an impairment of α-MSH-POMC neuron differentiation. CONCLUSIONS: These findings suggest that gestational exposure to HFD decreases the expression of IGF2BP1 in the hypothalami of male offspring and destabilizes Ramp3 mRNA, which leads to amylin resistance. The subsequent impairment of POMC neuron differentiation induces sex-specific metabolic disorders in adulthood.


Asunto(s)
Diferenciación Celular , Dieta Alta en Grasa/efectos adversos , Hipotálamo/metabolismo , Neuronas/metabolismo , Proopiomelanocortina/metabolismo , Receptores de Polipéptido Amiloide de Islotes Pancreáticos/metabolismo , Proteína Relacionada con Agouti/metabolismo , Animales , Núcleo Arqueado del Hipotálamo/metabolismo , Peso Corporal , Femenino , Células HEK293 , Humanos , Polipéptido Amiloide de los Islotes Pancreáticos/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Neurogénesis , Neuropéptido Y/metabolismo , Embarazo , Proteínas de Unión al ARN/metabolismo , Proteína 3 Modificadora de la Actividad de Receptores/genética , Proteína 3 Modificadora de la Actividad de Receptores/metabolismo , Células Madre , alfa-MSH/metabolismo
2.
Physiol Behav ; 139: 202-9, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25449399

RESUMEN

Several hypotheses for the causes of the obesity epidemic in the US have been proposed. One such hypothesis is that dietary intake patterns have significantly shifted to include unprecedented amounts of refined sugar. We set out to determine if different sugars might promote changes in the hypothalamic mechanisms controlling food intake by measuring several hypothalamic peptides subsequent to overnight access to dilute glucose, sucrose, high fructose corn syrup, or fructose solutions. Rats were given access to food, water and a sugar solution for 24h, after which blood and tissues were collected. Fructose access (as opposed to other sugars that were tested) resulted in a doubling of circulating triglycerides. Glucose consumption resulted in upregulation of 7 satiety-related hypothalamic peptides whereas changes in gene expression were mixed for remaining sugars. Also, following multiple verification assays, 6 satiety related peptides were verified as being affected by sugar intake. These data provide evidence that not all sugars are equally effective in affecting the control of intake.


Asunto(s)
Regulación del Apetito/fisiología , Sacarosa en la Dieta/administración & dosificación , Fructosa/administración & dosificación , Glucosa/administración & dosificación , Jarabe de Maíz Alto en Fructosa/administración & dosificación , Hipotálamo/fisiología , Animales , Glucemia , Peso Corporal , Colecistoquinina/metabolismo , Hormona Liberadora de Corticotropina/metabolismo , Ingestión de Alimentos/fisiología , Hormona del Crecimiento/metabolismo , Insulina/sangre , Masculino , Ratas Sprague-Dawley , Proteína 3 Modificadora de la Actividad de Receptores/metabolismo , Hormona Liberadora de Tirotropina/metabolismo , Triglicéridos/sangre , Factor de Necrosis Tumoral alfa/metabolismo
4.
Curr Pharm Biotechnol ; 12(9): 1427-39, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21506909

RESUMEN

OBJECTIVE: This study aimed to explore the effect of onion extract on endogenous hydrogen sulfide (H2S) and adrenomedulin (ADM) and on atherosclerotic progression in rats with atherosclerosis (AS). METHODS AND RESULTS: Male Sprague-Dawley rats were randomly divided into control, AS and AS+onion groups. Ultrastructure of aorta and atherosclerotic lesions both in aorta and in coronary artery were detected. Plasma and aortic H2S were detected by using a sulfide- sensitive electrode. Plasma and aortic ADM was determined with radioimmunoassay. Cystathionine-γ-lyase (CSE), calcitonin receptor-like receptor (CRLR), receptor activity-modifying protein (RAMP1, RAMP2 and RAMP3) mRNA expressions were analysed. Glutathione peroxidase (GSH-PX), superoxide dismutase (SOD), malondialdehyde (MDA), nitric oxide (NO) and NO synthase (NOS) contents in plasma, SOD1, SOD2 and ICAM-1 expressions in aorta were detected. Rats in the AS group showed marked atherosclerotic lesions both in aorta and in coronary artery but decreased aortic H2S production. Decreased plasma and aortic ADM content, but increased levels of aortic CRLR, RAMP2 and RAMP3 mRNAs were observed. Plasma GSH-PX and SOD were reduced but MDA elevated. Plasma ICAM-1 and NO contents and iNOS activity were increased. Onion extract, however, lessened atherosclerotic lesions and increased endogenous aortic H2S production, but decreased plasma ADM content, aortic ADM content and aortic CRLR, RAMP2 and RAMP3 mRNAs. In addition, it increased plasma GSH-PX level and SOD activities but reduced MDA; it decreased inflammatory response but increased plasma eNOS activity and NO content. CONCLUSIONS: Onion extract exerted a marked antiatherogenic effect in association with the up-regulation of the endogenous CSE/H2S pathway but down-regulation of the ADM/CRLR family in atherosclerotic rats.


Asunto(s)
Adrenomedulina/metabolismo , Aterosclerosis/tratamiento farmacológico , Sulfuro de Hidrógeno/metabolismo , Cebollas , Extractos Vegetales/uso terapéutico , Adrenomedulina/sangre , Animales , Aorta/efectos de los fármacos , Aorta/metabolismo , Aorta/ultraestructura , Aterosclerosis/sangre , Aterosclerosis/metabolismo , Proteína Similar al Receptor de Calcitonina/genética , Vasos Coronarios/efectos de los fármacos , Vasos Coronarios/patología , Cistationina gamma-Liasa/genética , Cistationina gamma-Liasa/metabolismo , Glutatión Peroxidasa/sangre , Sulfuro de Hidrógeno/sangre , Molécula 1 de Adhesión Intercelular/sangre , Molécula 1 de Adhesión Intercelular/metabolismo , Masculino , Malondialdehído/sangre , Microscopía Electrónica de Transmisión , Extractos Vegetales/farmacología , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Proteína 1 Modificadora de la Actividad de Receptores/genética , Proteína 2 Modificadora de la Actividad de Receptores/genética , Proteína 3 Modificadora de la Actividad de Receptores/genética , Superóxido Dismutasa/sangre , Superóxido Dismutasa/metabolismo , Superóxido Dismutasa-1
5.
Eur J Pharmacol ; 549(1-3): 117-23, 2006 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-16987513

RESUMEN

Intermedin is a novel member of the calcitonin/calcitonin gene-related peptide (CGRP) family peptide, which has vasodilatory and hypotensive actions identical to those of adrenomedullin and CGRP. Cleavage sites located between 2 basic amino acids at Arg93-Arg94 result in the production of prepro-intermedin95-147, namely intermedin1-53. The bioactive action of intermedin1-53 and its physiological significance are unclear. In this work, we aimed to explore the effects of intermedin1-53 on acute myocardial injury induced by isoproterenol. Myocardial ischemia injury in rats was induced by subcutaneous injection of a high dose of isoproterenol, and the therapeutic effect of intermedin1-53 was observed. Plasma lactate dehydrogenase activity, myocardial and plasma malondialdehyde content were higher in the isoproterenol group than that in controls. Isoproterenol-treated rats showed lower maximal rate of increase and decrease of left-ventricle pressure development (+/-left-ventricle dp/dtmax) and higher left-ventricle end-diastolic pressure (all P<0.01), which suggested severe heart failure and myocardial injury. Semi-quantitative RT-PCR analysis showed that the gene expression of calcitonin receptor-like receptor and receptor-activity-modifying protein (RAMP)1, RAMP2 and RAMP3 in ventricular myocardia were up-regulated by 79% (P<0.01), 48% (P<0.01), 31% (P<0.05) and 130% (P<0.01), respectively, compared with controls. In myocardial sarcolemmal membranes, the maximum binding capacity for [125I]-intermedin1-53 was increased by 118% (P<0.01) in the isoproterenol group compared with controls. Rats treated with low dosage intermedin1-53 (5 nmol/kg/day, 2 days) showed 21% (P<0.05) higher myocardial cAMP content, 18% and 31% higher+left-ventricle dp/dtmax and -left-ventricle dp/dtmax respectively, 288% lower left-ventricle end-diastolic pressure (all P<0.01), and attenuated myocardial lactate dehydrogenase leakage and malondialdehyde formation (all P<0.01). Treatment with high dosage intermedin1-53 (20 nmol/kg/day, 2 days) gave better results than that with low dosage intermedin1-53. These results suggest that the intermedin receptor system was up-regulated in isoproterenol-induced myocardial ischemic injury and intermedin1-53 might play a pivotal cardioprotective role in such injury.


Asunto(s)
Adrenomedulina/farmacología , Isoproterenol/toxicidad , Infarto del Miocardio/prevención & control , Neuropéptidos/farmacología , Fragmentos de Péptidos/farmacología , Adrenomedulina/química , Adrenomedulina/metabolismo , Animales , Proteína Similar al Receptor de Calcitonina , AMP Cíclico/metabolismo , Relación Dosis-Respuesta a Droga , Expresión Génica/efectos de los fármacos , Inyecciones Subcutáneas , Péptidos y Proteínas de Señalización Intracelular/genética , Radioisótopos de Yodo , Isoproterenol/administración & dosificación , L-Lactato Deshidrogenasa/sangre , Masculino , Malondialdehído/sangre , Malondialdehído/metabolismo , Proteínas de la Membrana/genética , Infarto del Miocardio/inducido químicamente , Infarto del Miocardio/fisiopatología , Miocardio/metabolismo , Miocardio/patología , Neuropéptidos/química , Neuropéptidos/metabolismo , Fragmentos de Péptidos/metabolismo , Unión Proteica/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Proteína 2 Modificadora de la Actividad de Receptores , Proteína 3 Modificadora de la Actividad de Receptores , Proteínas Modificadoras de la Actividad de Receptores , Receptores de Calcitonina/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sarcolema/efectos de los fármacos , Sarcolema/metabolismo
6.
Mol Cell Endocrinol ; 223(1-2): 27-34, 2004 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-15279908

RESUMEN

The serum estrogen surge in the uterus triggers precisely-timed physiological and biochemical responses required establishing and maintaining pregnancy. Previous reports have shown that consumption of phytoestrogen-containing plants may disrupt the precise control of pregnancy. To evaluate the effects of phytoestrogens in the uterus, we screened for estradiol (E2)-inducible genes in immature rat uteri. We identified the gene for receptor-activity-modifying protein 2 (Ramp2), known to be a component of the adrenomedullin (ADM) receptor, as responsive to both E2 and the phytoestrogen coumestrol (Cou). We further examined the expression of ADM and ADM signaling components Ramp2, Ramp3, and CRLR in the immature rat uterus and found that both E2 and Cou regulated these genes expression. In addition, treatment with ADM increased uterine weight and edema similar to that observed after Cou treatment. Our findings indicated that the phytoestrogen caused the abnormal induction of vasoactive factors in the uterus.


Asunto(s)
Estradiol/análogos & derivados , Estradiol/farmacología , Regulación de la Expresión Génica , Péptidos/genética , Fitoestrógenos/farmacología , Receptores de Péptidos/genética , Útero/metabolismo , Adrenomedulina , Animales , Proteína Similar al Receptor de Calcitonina , Cumestrol/farmacología , Estradiol/fisiología , Estro/fisiología , Femenino , Fulvestrant , Péptidos y Proteínas de Señalización Intracelular , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Péptidos/metabolismo , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Proteína 2 Modificadora de la Actividad de Receptores , Proteína 3 Modificadora de la Actividad de Receptores , Proteínas Modificadoras de la Actividad de Receptores , Receptores de Adrenomedulina , Receptores de Calcitonina/genética , Receptores de Calcitonina/metabolismo , Receptores de Péptidos/biosíntesis , Útero/citología , Útero/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA